Revenue Performance - Net revenue for Q1 2025 was 788.7million,adecreaseof2.7810.4 million in Q1 2024[101]. - Organic revenue growth increased by 1.9% in Q1 2025, driven by a 4.2% increase in Hygiene, Health and Consumable Adhesives and a 2.2% increase in Building Adhesive Solutions[101]. - The Engineering Adhesives segment reported net revenue of 236.8millioninQ12025,a4.0226.0 million in Q1 2024[119]. - Net revenue for the Hygiene, Health and Consumable Adhesives segment was flat at 0.0millioninQ12025comparedtoQ12024,withorganicgrowthof4.2236.8 million in Q1 2025, driven by an 8.7% contribution from M&A, despite a decline in organic growth of (1.9)%[124]. - Building Adhesive Solutions reported a net revenue increase of 2.2% to 183.7millioninQ12025,withorganicgrowthof2.213.2 million, down 57.4% from 31.0millioninQ12024,withdilutedearningspersharedecreasingfrom0.55 to 0.24[98][114].−Grossprofitmargindecreasedby70basispointsto28.8180.6 million in Q1 2025, representing 22.9% of net revenue, up from 21.3% in Q1 2024[105]. - Segment operating income for Engineering Adhesives rose by 8.5% to 28.0million,whilesegmentoperatingmarginimprovedby40basispointsto11.86.6 million, with segment operating margin declining by 40 basis points to 3.6%[125]. Cash Flow and Debt - Free cash flow for Q1 2025 was (85.9)million,asignificantdecreasefrom4.1 million in Q1 2024[138]. - Net cash provided by operating activities was (52.9)millioninQ12025,comparedto47.4 million in Q1 2024[140]. - Total cash and cash equivalents as of March 1, 2025, were 105.7million,downfrom165.2 million as of March 2, 2024[130]. - Total long and short-term debt increased to 2,180.0millionasofMarch1,2025,comparedto1,830.8 million as of March 2, 2024, resulting in a total debt to total capital ratio of 55.1%[130]. - Changes in net working capital resulted in a cash use of 27.5millioninQ12025,comparedtoacashsourceof34.3 million in Q1 2024[141]. Investment and Financing Activities - Net cash used in investing activities was 121.4millioninQ12025,upfrom42.7 million in Q1 2024, with property, plant, and equipment purchases at 33.0million[143].−Thecompanypaid162.0 million in cash for business acquisitions during Q1 2025 and received 75.8millionfromthesaleofNAFlooring[144].−Netcashprovidedbyfinancingactivitieswas111.4 million in Q1 2025, compared to a cash use of 16.9millioninQ12024[145].−Borrowingsontherevolvingcreditfacilitytotaled526.3 million in Q1 2025, with repayments amounting to 359.5million[145].−Cashdividendspaidincreasedto12.2 million in Q1 2025 from 11.2millioninQ12024,whilecommonstockrepurchasesroseto44.4 million from 6.2million[145].OtherFinancialMetrics−Otherincome,netdecreasedby113.31.5 million in Q1 2025, compared to 3.2millioninQ12024[107].−Interestexpenseslightlyincreasedto32.0 million in Q1 2025 from 31.9millioninQ12024[108].−Incomefromequitymethodinvestmentsdecreasedby50.00.5 million in Q1 2025, down from 1.0millioninQ12024[113].−Tradereceivablesprovided13.9 million in cash in Q1 2025, down from 56.9millioninQ12024,withDaysSalesOutstanding(DSO)increasingto61days[142].−Inventoryusagedecreasedto27.1 million in Q1 2025 from 50.2millioninQ12024,withinventorydaysonhandat79days[142].−Tradepayablesresultedinacashuseof14.3 million in Q1 2025, compared to a cash source of 27.6millioninQ12024,withDaysPayableOutstandingremainingat73days[142].RestructuringandMarketRisks−Restructuringplansareexpectedtoincurcostsofapproximately60.0 million to 65.0million,with61.7 million already incurred as of March 1, 2025[99]. - The company remains exposed to market risks including interest rates and foreign currency rates, with no material changes reported since November 30, 2024[149].